{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:55:37Z","timestamp":1776167737963,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["ZQN-1107"],"award-info":[{"award-number":["ZQN-1107"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J01297"],"award-info":[{"award-number":["2022J01297"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangzhou in China","award":["107167815080"],"award-info":[{"award-number":["107167815080"]}]},{"name":"Natural Science Foundation of Guangdong Province in China","award":["2018A030313537"],"award-info":[{"award-number":["2018A030313537"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04174-y","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:04:49Z","timestamp":1772795089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selenium nanoparticles with bioorthogonal targeting to boost CAR-cell therapy for colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jinfan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4174_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","volume":"16","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang G, Wan X. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol. 2023;16:97.","journal-title":"J Hematol Oncol"},{"key":"4174_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40364-022-00364-6","volume":"10","author":"L Zhang","year":"2022","unstructured":"Zhang L, Meng Y, Feng X, Han Z. CAR-NK cells for cancer immunotherapy: from bench to bedside. Biomark Res. 2022;10:12.","journal-title":"Biomark Res"},{"key":"4174_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, et al. Use of CAR-Transduced natural killer cells in CD19-Positive lymphoid tumors. N Engl J Med. 2020;382:545\u201353.","journal-title":"N Engl J Med"},{"key":"4174_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, Mohanty V, Dede M, Nieto Y, Uprety N, et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial. Nat Med. 2024;30:772\u201384.","journal-title":"Nat Med"},{"key":"4174_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00281-018-0721-x","volume":"41","author":"ML Saetersmoen","year":"2019","unstructured":"Saetersmoen ML, Hammer Q, Valamehr B, Kaufman DS, Malmberg KJ. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Semin Immunopathol. 2019;41:59\u201368.","journal-title":"Semin Immunopathol"},{"key":"4174_CR6","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41590-023-01659-y","volume":"24","author":"OK Dagher","year":"2023","unstructured":"Dagher OK, Posey AD. Forks in the road for CAR T and CAR NK cell cancer therapies. Nat Immunol. 2023;24:1994\u20132007.","journal-title":"Nat Immunol"},{"key":"4174_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.omtm.2021.10.014","volume":"23","author":"Z Du","year":"2021","unstructured":"Du Z, Ng YY, Zha S, Wang S. PiggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells. Mol Ther Methods Clin Dev. 2021;23:582\u201396.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4174_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40425-017-0275-9","volume":"5","author":"V Kremer","year":"2017","unstructured":"Kremer V, Ligtenberg MA, Zendehdel R, Seitz C, Duivenvoorden A, Wennerberg E, Col\u00f3n E, Scherman-Plogell AH, Lundqvist A. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. J Immunother Cancer. 2017;5:73.","journal-title":"J Immunother Cancer"},{"key":"4174_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061743","author":"KM Coyle","year":"2023","unstructured":"Coyle KM, Hawke LG, Ormiston ML. Addressing natural killer cell dysfunction and plasticity in cell-based cancer therapeutics. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15061743.","journal-title":"Cancers"},{"key":"4174_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02327-z","author":"K Pan","year":"2022","unstructured":"Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan C-x, Zhu Z. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022. https:\/\/doi.org\/10.1186\/s13046-022-02327-z.","journal-title":"J Exp Clin Cancer Res"},{"key":"4174_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"4174_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201907568","author":"S Gao","year":"2020","unstructured":"Gao S, Li T, Guo Y, Sun C, Xianyu B, Xu H. Selenium-containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Adv Mater. 2020. https:\/\/doi.org\/10.1002\/adma.201907568.","journal-title":"Adv Mater"},{"key":"4174_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201800128","volume":"2","author":"J Lou","year":"2019","unstructured":"Lou J, Zhang L, Zheng G. Advancing cancer immunotherapies with nanotechnology. Adv Ther. 2019;2:1800128.","journal-title":"Adv Ther"},{"key":"4174_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120224","author":"K Wang","year":"2020","unstructured":"Wang K, Ye H, Zhang X, Wang X, Yang B, Luo C, et al. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials. 2020. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120224.","journal-title":"Biomaterials"},{"key":"4174_CR15","doi-asserted-by":"publisher","first-page":"120748","DOI":"10.1016\/j.carbpol.2023.120748","volume":"311","author":"R Tan","year":"2023","unstructured":"Tan R, Ge J, Wang C, Wan Y, Yang X. Diselenide-triggered hydroxyethyl starch conjugate nanoparticles with cascade drug release properties for potentiating chemo-photodynamic therapy. Carbohydr Polym. 2023;311:120748.","journal-title":"Carbohydr Polym"},{"key":"4174_CR16","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1039\/C9CC00252A","volume":"55","author":"C Liu","year":"2019","unstructured":"Liu C, Xia J, Ji S, Fan Z, Xu H. Visible-light-induced metathesis reaction between diselenide and ditelluride. Chem Commun. 2019;55:2813\u20136.","journal-title":"Chem Commun"},{"key":"4174_CR17","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ac0a8f","author":"D Zhu","year":"2021","unstructured":"Zhu D, Chen W, Lin W, Li Y, Liu X. Reactive oxygen species-responsive nanoplatforms for nucleic acid-based gene therapy of cancer and inflammatory diseases. Biomed Mater. 2021. https:\/\/doi.org\/10.1088\/1748-605X\/ac0a8f.","journal-title":"Biomed Mater"},{"key":"4174_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2020.127108","author":"C Fu","year":"2021","unstructured":"Fu C, Wei R, Xu P, Luo S, Zhang C, Kankala RK, et al. Supercritical fluid-assisted fabrication of diselenide-bridged polymeric composites for improved indocyanine green-guided photodynamic therapy. Chem Eng J. 2021. https:\/\/doi.org\/10.1016\/j.cej.2020.127108.","journal-title":"Chem Eng J"},{"key":"4174_CR19","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.4049\/jimmunol.1100610","volume":"187","author":"M Enqvist","year":"2011","unstructured":"Enqvist M, Nilsonne G, Hammarfjord O, Wallin RP, Bj\u00f6rkstr\u00f6m NK, Bj\u00f6rnstedt M, et al. Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94\/NKG2A-positive NK cells. J Immunol. 2011;187:3546\u201354.","journal-title":"J Immunol"},{"key":"4174_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202108167","author":"Z Wei","year":"2022","unstructured":"Wei Z, Yi Y, Luo Z, Gong X, Jiang Y, Hou D, et al. Selenopeptide nanomedicine activates natural killer cells for enhanced tumor chemoimmunotherapy. Adv Mater. 2022. https:\/\/doi.org\/10.1002\/adma.202108167.","journal-title":"Adv Mater"},{"key":"4174_CR21","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1002\/anie.201914453","volume":"59","author":"T Li","year":"2020","unstructured":"Li T, Pan S, Gao S, Xiang W, Sun C, Cao W, et al. Diselenide-Pemetrexed assemblies for combined cancer Immuno-, radio-, and chemotherapies. Angew Chem Int Ed Engl. 2020;59:2700\u20134.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4174_CR22","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1021\/acsnano.3c01733","volume":"17","author":"H Ye","year":"2023","unstructured":"Ye H, Wang K, Zhao J, Lu Q, Wang M, Sun B, Shen Y, Liu H, Pan\u00e9 S, Chen X-Z, et al. In situ sprayed nanovaccine suppressing Exosomal PD-L1 by golgi apparatus disorganization for postsurgical melanoma immunotherapy. ACS Nano. 2023;17:10637\u201350.","journal-title":"ACS Nano"},{"key":"4174_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nchembio0605-13","volume":"1","author":"JA Prescher","year":"2005","unstructured":"Prescher JA, Bertozzi CR. Chemistry in living systems. Nat Chem Biol. 2005;1:13\u201321.","journal-title":"Nat Chem Biol"},{"key":"4174_CR24","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1021\/bi9007726","volume":"48","author":"MD Best","year":"2009","unstructured":"Best MD. Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry. 2009;48:6571\u201384.","journal-title":"Biochemistry"},{"key":"4174_CR25","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1002\/anie.202015625","volume":"60","author":"A Lamoot","year":"2021","unstructured":"Lamoot A, Uvyn A, Kasmi S, De Geest BG. Covalent cell surface conjugation of nanoparticles by a combination of metabolic labeling and click chemistry. Angew Chem Int Ed Engl. 2021;60:6320\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4174_CR26","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1021\/nn501028b","volume":"8","author":"H Pan","year":"2014","unstructured":"Pan H, Zhang P, Gao D, Zhang Y, Li P, Liu L, et al. Noninvasive visualization of respiratory viral infection using bioorthogonal conjugated near-infrared-emitting quantum dots. ACS Nano. 2014;8:5468\u201377.","journal-title":"ACS Nano"},{"key":"4174_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211370","author":"S Pan","year":"2023","unstructured":"Pan S, Guan J, Xianyu B, Tan Y, Li T, Xu H. A nanotherapeutic strategy to reverse NK cell exhaustion. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202211370.","journal-title":"Adv Mater"},{"key":"4174_CR28","doi-asserted-by":"publisher","first-page":"e2304172","DOI":"10.1002\/adma.202304172","volume":"35","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zhou A, Chen W, Yan Y, Chen K, Zhou X, Tian Z, Zhang X, Wu H, Fu Z, Ning X. An integrative bioorthogonal nanoengineering strategy for dynamically constructing heterogenous tumor spheroids. Adv Mater. 2023;35:e2304172.","journal-title":"Adv Mater"},{"key":"4174_CR29","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.bioactmat.2020.09.025","volume":"6","author":"H Pan","year":"2021","unstructured":"Pan H, Li W, Chen Z, Luo Y, He W, Wang M, Tang X, He H, Liu L, Zheng M, et al. Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor. Bioactive Mater. 2021;6:951\u201362.","journal-title":"Bioactive Mater"},{"key":"4174_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201804383","author":"W Li","year":"2018","unstructured":"Li W, Pan H, He H, Meng X, Ren Q, Gong P, et al. Bio-orthogonal T cell targeting strategy for robustly enhancing cytotoxicity against tumor cells. Small. 2018. https:\/\/doi.org\/10.1002\/smll.201804383.","journal-title":"Small"},{"key":"4174_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202202603","author":"D Meng","year":"2022","unstructured":"Meng D, Pan H, He W, Jiang X, Liang Z, Zhang X, et al. In situ activated NK cell as bio-orthogonal targeted live\u2010cell nanocarrier augmented solid tumor immunotherapy. Adv Funct Mater. 2022. https:\/\/doi.org\/10.1002\/adfm.202202603.","journal-title":"Adv Funct Mater"},{"key":"4174_CR32","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1021\/acs.oprd.9b00406","volume":"23","author":"SA McNelles","year":"2019","unstructured":"McNelles SA, Pantaleo JL, Adronov A. Highly efficient multigram synthesis of Dibenzoazacyclooctyne (DBCO) without chromatography. Org Process Res Dev. 2019;23:2740\u20135.","journal-title":"Org Process Res Dev"},{"key":"4174_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115899","author":"E Wrona","year":"2021","unstructured":"Wrona E, Borowiec M, Potemski P. CAR-NK cells in the treatment of solid tumors. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115899.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04174-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:05:31Z","timestamp":1776164731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04174-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4174"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04174-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments and care were carried out in accordance with protocols approved by the Medical Ethics Committee of NanFang Hospital of Southern Medical University (Approval No. SMUL2022175).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript, and agree to submit for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}